163 related articles for article (PubMed ID: 12582404)
1. Scleroderma-like cutaneous lesions induced by paclitaxel: a case study.
Kupfer I; Balguerie X; Courville P; Chinet P; Joly P
J Am Acad Dermatol; 2003 Feb; 48(2):279-81. PubMed ID: 12582404
[TBL] [Abstract][Full Text] [Related]
2. Fixed erythrodysaesthesia plaque due to intravenous injection of docetaxel.
Chu CY; Yang CH; Yang CY; Hsiao GH; Chiu HC
Br J Dermatol; 2000 Apr; 142(4):808-11. PubMed ID: 10792238
[TBL] [Abstract][Full Text] [Related]
3. Scleroderma in association with the use of docetaxel (taxotere) for breast cancer.
Hassett G; Harnett P; Manolios N
Clin Exp Rheumatol; 2001; 19(2):197-200. PubMed ID: 11326485
[TBL] [Abstract][Full Text] [Related]
4. Photodistributed erythema multiforme: paclitaxel-related, photosensitive conditions in patients with cancer.
Cohen PR
J Drugs Dermatol; 2009 Jan; 8(1):61-4. PubMed ID: 19180897
[TBL] [Abstract][Full Text] [Related]
5. Scleroderma-like cutaneous lesions induced by paclitaxel and carboplatin for ovarian carcinoma, not a single course of carboplatin, but re-induced and worsened by previously administrated paclitaxel.
Konishi Y; Sato H; Sato N; Fujimoto T; Fukuda J; Tanaka T
J Obstet Gynaecol Res; 2010 Jun; 36(3):693-6. PubMed ID: 20598060
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
[No Abstract] [Full Text] [Related]
7. Paclitaxel-induced cutaneous change mimicking malignancy in a previous cutaneous eruption.
Salas-Martínez AM; Caballero CI; González-Vela MC; Mira MC; Laso-Dosal F; Val-Bernal JF
Rev Esp Patol; 2018; 51(3):188-192. PubMed ID: 30012313
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous fibrosis induced by docetaxel: a case report.
Cleveland MG; Ajaikumar BS; Reganti R
Cancer; 2000 Mar; 88(5):1078-81. PubMed ID: 10699898
[TBL] [Abstract][Full Text] [Related]
9. Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature.
Verhulst L; Noë E; Morren MA; Verslype C; Van Cutsem E; Van den Oord JJ; De Haes P
Int J Dermatol; 2018 Sep; 57(9):1075-1079. PubMed ID: 29938783
[TBL] [Abstract][Full Text] [Related]
10. Histopathological improvement of scleroderma induced by paclitaxel in a patient with breast cancer.
Ohashi A; Minagawa A; Ashida A; Koga H; Uhara H; Okuyama R
J Dermatol; 2015 Dec; 42(12):1198-9. PubMed ID: 26333146
[No Abstract] [Full Text] [Related]
11. Cutaneous fixed drug eruption to paclitaxel; a case report.
Baykal C; Erkek E; Tutar E; Yüce K; Ayhan A
Eur J Gynaecol Oncol; 2000; 21(2):190-1. PubMed ID: 10843484
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases.
Battafarano DF; Zimmerman GC; Older SA; Keeling JH; Burris HA
Cancer; 1995 Jul; 76(1):110-5. PubMed ID: 8630861
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma and the taxanes. Is there really a link?
Farrant PB; Mortimer PS; Gore M
Clin Exp Dermatol; 2004 Jul; 29(4):360-2. PubMed ID: 15245529
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-induced Scleroderma in A Breast Cancer Patient: A Case Report.
Kılıç MÖ; Yalaza M; Bilgiç Cİ; Dener C
J Breast Health; 2015 Apr; 11(2):95-97. PubMed ID: 28331700
[TBL] [Abstract][Full Text] [Related]
15. Scleroderma induced by paclitaxel.
Pedersen JV; Jensen S; Krarup-Hansen A; Riis L
Acta Oncol; 2010 Aug; 49(6):866-8. PubMed ID: 20446892
[No Abstract] [Full Text] [Related]
16. Taxol-induced acral erythema.
de Argila D; Dominguez JD; Iglesias L
Dermatology; 1996; 192(4):377-8. PubMed ID: 8864381
[TBL] [Abstract][Full Text] [Related]
17. Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer.
Eich D; Scharffetter-Kochanek K; Eich HT; Tantcheva-Poor I; Krieg T
Am J Clin Oncol; 2002 Dec; 25(6):599-602. PubMed ID: 12478008
[TBL] [Abstract][Full Text] [Related]
18. Hypersensitivity to paclitaxel manifested as a bullous fixed drug eruption.
Young PC; Montemarano AD; Lee N; Sau P; Weiss RB; James WD
J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):313-4. PubMed ID: 8642105
[No Abstract] [Full Text] [Related]
19. Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.
Ketpueak T; Chanloung W; Nan KN; Pongsananurak C; Kasitanon N; Louthrenoo W
Clin Rheumatol; 2022 Dec; 41(12):3887-3896. PubMed ID: 36085204
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.
Dasanu CA; Alexandrescu DT
South Med J; 2008 Nov; 101(11):1161-2. PubMed ID: 19088531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
